We are live on ! Find out more
SOCM

SR One Capital Management Portfolio holdings

AUM $915M
1-Year Est. Return 209.71%
This Fund
S&P 500
This Quarter Est. Return
+34.93%
1 Year Est. Return
+209.71%
3 Year Est. Return
+484.66%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$274M
AUM Growth
+$55.2M
Cap. Flow
+$31.7M
Cap. Flow %
11.58%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SPRY icon
ARS Pharmaceuticals
SPRY
+$19.5M
2
DSGN icon
Design Therapeutics
DSGN
+$12.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$170M 62.2%
5,500,007
– –
DSGN icon
2
Design Therapeutics
DSGN
$915M
$67M 24.44%
6,526,476
+900,000
+16% +$12.2M
SPRY icon
3
ARS Pharmaceuticals
SPRY
$591M
$25.7M 9.37%
+3,009,677
New +$19.5M
NKTX icon
4
Nkarta
NKTX
$167M
$7.99M 2.92%
1,333,333
– –
EFTR
5
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2.93M 1.07%
272,885
– –

Similar funds

PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
SC
Sierra Capital Miami, Florida $918M AUM 8.25% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
FFL
Flat Footed LLC Wilson, Wyoming $920M AUM 86.47% 1-Year Est. Return

SR One Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, SR One Capital Management held 5 positions worth $274M, up 25% from $219M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SR One Capital Management deployed $31.7M of net new capital in Q4 2022, opening 1 new position and adding to 1 existing holding. Its largest new stake was ARS Pharmaceuticals: 3,009,677 shares worth $25.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SR One Capital Management's largest Q4 2022 buy was ARS Pharmaceuticals: 3,009,677 shares worth $25.7M.
  • SR One Capital Management added most to Design Therapeutics in Q4 2022, an estimated $12.2M increase.
  • SR One Capital Management's ten largest holdings make up 100% of its $274M portfolio in Q4 2022.
  • SR One Capital Management opened 1 new position and closed 0 in Q4 2022.
  • SR One Capital Management's portfolio value rose 25% quarter-over-quarter to $274M.

Based on SR One Capital Management's 13F filing for Q4 2022, filed 8 Feb 2023.